ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wain, W. H.
Right arrow Articles by Ross, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wain, W. H.
Right arrow Articles by Ross, D. N.

The Annals of Thoracic Surgery, Vol 33, 562-569, Copyright © 1982 by The Society of Thoracic Surgeons


ARTICLES

Aortic valve replacement with Starr-Edwards valves over 14 years

WH Wain, PJ Drury and DN Ross

Three hundred thirteen patients underwent aortic valve replacement with 319 Starr-Edwards caged-ball prostheses and have been followed for 1 to 14 years. Hospital mortality (24.8%) and first-year mortality (4.8%) suggest that this is a high-risk group. Overall postoperative patients survival was 37.1%, with 18.8% free from any event, at 14 years. Thromboembolism was the most significant single event (a probability of 18.7% at 14 years), and the Series 2300/2320 valves were associated with a probability of hemolysis of nearly 80% over 13 years. Patients who underwent valve replacement before 1973 had a significantly greater probability of late death (31.1%) and of complications (47.1%) during the first 5 years. Those patients undergoing replacement after 1973 had a significantly greater probability of thromboembolic episodes (15.4%). Starr-Edwards cage-ball prosthesis provide an acceptable valve replacement for high-risk patients. However, the overall complication rate of 81.2% over 14 years, compared with 78% for homograft valves for the same period, does not support the adoption of this prosthesis as the valve of first choice at this hospital.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. A. Orszulak, H. V. Schaff, F. J. Puga, G. K. Danielson, C. J. Mullany, B. J. Anderson, and D. M. Ilstrup
Event Status of the Starr-Edwards Aortic Valve to 20 Years: A Benchmark for Comparison
Ann. Thorac. Surg., March 1, 1997; 63(3): 620 - 626.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
O. Lund
Late Chronic Hemolysis after Valve Replacement for Aortic Stenosis. Relation to Residual Hypertrophy and Impaired Left Ventricular Function
Angiology, October 1, 1990; 41(10): 836 - 847.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1982 by The Society of Thoracic Surgeons.